News | February 17, 2022
Moderna’s Covid-19 vaccine approved in Australia for children (6-11 years)
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
Up to 100 million mRNA vaccine doses could be produced in Australia each year
It is a novel oral NLRP3 inflammasome inhibitor
The company plans to expand its portfolio in regulated markets aggressively
The consideration to be paid will be AUD 2.0 mn for 12.5% stake.
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
The partnership aims to fuse Avantium’s breakthrough materials with Packamama’s expertise in low-emission, innovative wine bottles
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories
Subscribe To Our Newsletter & Stay Updated
